Janet Shimotake, MD

Education
2019 - Diversity, Equity, and Inclusion Champion Training, University of California
06/2003 - Pediatrics Residency, University of Chicago Comer Children's Hospital
MD, 06/1999 - , University of Chicago, Pritzker SOM

  1. MacKenzie TC, Lianoglou BR, Gonzalez J, Dvorak CC, Kharbanda S, Herzeg A, Canepa E, Kreger EM, Frascoli M, Sper R, Gupta A, Leung J, Tang Q, Sinha R, Worthington AK, Gano D, Coco Bakkour S, Chafets D, Keller RL, Shimotake J, Lal A, Glenn OA, Moon-Grady A, Vichinsky EP. In Utero Hematopoietic Cell Transplantation in Fetuses with Alpha Thalassemia Major: A Phase 1 Clinical Trial. Blood advances 2026. PMID: 41984996


  2. Shimotake J, Derugin N, Wendland M, Vexler ZS, Ferriero DM. Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. Stroke 2010. PMID: 20101028